Skip to content

Advertisement

Immune-inflammatory responses in the Elderly: an update

A long life in a healthy, vigorous, youthful body has always been one of humanity’s greatest dreams. In this collection, anti-ageing strategies have been discussed based on the control of immune-inflammatory responses, aimed not only to slow the ageing process, but also to delay or avoid the onset of age-related diseases such as cancer or combat infectious diseases. Intriguingly, there is a connection between these responses and nutrient sensing pathways already known to delay age-related diseases and promote longevity.

Articles

Most accessed articles RSS

View all articles

2016

Thematic series
Nutrigerontology: a key for achieving successful ageing and longevity
Collection published: April/ May 2016

 

2015

Cross journal collection
Day of Immunology 2015
Collection published: 28 April 2015

2012

Thematic series
Positive biology: the centenarian lesson
Immunity & Ageing
Collection published: 23 April 2012

Aims and scope

"Ageing seems to be the only available way to live a long life." Daniel Auber

Immunity & Ageing publishes articles on all aspects of ageing examined from an immunological point of view.

Read more

Latest Tweets

About the Editors

Graham Pawelec

Graham Pawelec was Professor of Experimental Immunology at the University of Tübingen, Germany for 20 years where he led the Tübingen Ageing and Tumour Immunology (TATI) group from 1999 to 2017. He remains affiliated part-time with the department at the Center for Medical Research, University of Tübingen and is currently affiliated with the Cancer Solutions Program, Health Sciences North Research Institute of Canada, Sudbury, ON, and is a Visiting Professor at Nottingham Trent University, UK, King´s College London, London, UK, and is an Honorary Professor at Manchester University, UK.

He has coordinated three European Union collaborative programs on immunosenescence (EUCAMBIS, ImAginE and T-CIA) and two on cancer vaccine research (EUCAPS, ESTDAB). He was a member of the Sanofi-Pasteur-MSD and Sanofi-Aventis Advisory Boards on Immunosenescence and Vaccination, and of the WHO Initiative for Vaccine Research Advisory Board on the Impact of Ageing on Vaccination. His research interests remain centered on vaccination, cancer immunology and immunotherapy, and immunogerontology.

Nan-ping Weng

Dr. Nan-ping Weng is tenured senior investigator, Chief of Lymphocyte Differentiation Section, Laboratory of Molecular Biology and Immunology at the National Insitute on Aging (NIA), NIH. He joined the Laboratory of Immunology at the NIA as a tenure-track investigator in 1997 and has been tenured senior investigator since 2006.

His laboratory focuses on the understanding of molecular and cellular mechanisms of T cell differentiation and age-associated decline of T cell functions. Particularly, he studies three areas: 1) Role of telomere/telomerase in lymphocyte differentiation, proliferation, and aging; 2) Epigenetic and transcriptional regulation of T cell differentiation and aging; and 3) Interrelation between diversity of general and antigen-specific αβ TCR repertoire and T cell functions.  

Founding Editor

Professor Calogero Caruso MD Professor of General Pathology and Director of Palermo University Medical School “Ippocrate”

Whether your interests are immunological aspects of ageing, age-related diseases and longevity, this journal can serve as an appropriate venue.

Advertisement

2017 Journal Metrics

Advertisement